SEARCH
Q4 Review: Biocon's Kiran Mazumdar Shaw On Earnings & FY23 Projections
NDTV Profit
2022-04-29
Views
19
Description
Share / Embed
Download This Video
Report
#Q4WithBQ | Biocon's Q4 net profit surpasses estimate but margins see a contraction on a yearly basis.
Executive Chairperson Kiran Mazumdar Shaw shares growth projections for FY23 along with strategies to boost growth. #BQLive
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x8afqla" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
16:17
Q2WithBQ With Biocon's Kiran Mazumdar Shaw
00:00
Profit Insights | Biocon's Kiran Mazumdar Shaw Exclusive | NDTV Profit
02:22
Corporate tax cut is a much needed reform, says Biocon's Kiran Mazumdar Shaw
12:25
Biocon’s Kiran Mazumdar Shaw On Who’ll Win The Battle Between ‘Innovators’ And Biosimilar Makers
01:31
Interview: Biocon MD, Kiran Mazumdar Shaw
11:29
Allow companies to provide booster doses to employees: Biocon chief Kiran Mazumdar-Shaw | EXCLUSIVE
14:54
Kiran Mazumdar-Shaw: Australia, New Zealand & Europe Will Be Strong Markets For Biocon
22:04
Don't think the budget has moved the needle in improving consumption, says Kiran Mazumdar Shaw of Biocon
10:25
Kiran Mazumdar Shaw of Biocon on business outlook
08:46
Kiran Mazumdar Shaw of Biocon on biosimilar & business outlook
00:53
Covid-19 | A message from Biocon chief Kiran Mazumdar Shaw
02:05
Biocon chief Kiran Mazumdar Shaw questions govt's Covid vaccine policy
